Kimberly Bergman

536 total citations
17 papers, 361 citations indexed

About

Kimberly Bergman is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kimberly Bergman has authored 17 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kimberly Bergman's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Bacillus and Francisella bacterial research (3 papers) and Pharmaceutical studies and practices (3 papers). Kimberly Bergman is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Bacillus and Francisella bacterial research (3 papers) and Pharmaceutical studies and practices (3 papers). Kimberly Bergman collaborates with scholars based in United States, Belgium and United Kingdom. Kimberly Bergman's co-authors include Keith M. Olsen, Mirjana Nesin, Jill Long, R. Phillips Heine, David Siegel, Jeanne S. Sheffield, Christine Nguyen, Mark Mirochnick, Rada Savic and Kelly E. Dooley and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Kimberly Bergman

16 papers receiving 345 citations

Peers

Kimberly Bergman
Maame Efua Sampah United States
Alberto Martín-Hidalgo Spain
Eduardo Martínez Spain
Patricia K. Mydlow United States
Nancy Perrottet Switzerland
Sahera Dirajlal‐Fargo United States
Augustine Ebonyi Nigeria
Joseph Stavola United States
Minh Lê France
Marita Stevens Belgium
Maame Efua Sampah United States
Kimberly Bergman
Citations per year, relative to Kimberly Bergman Kimberly Bergman (= 1×) peers Maame Efua Sampah

Countries citing papers authored by Kimberly Bergman

Since Specialization
Citations

This map shows the geographic impact of Kimberly Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Bergman more than expected).

Fields of papers citing papers by Kimberly Bergman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Bergman. The network helps show where Kimberly Bergman may publish in the future.

Co-authorship network of co-authors of Kimberly Bergman

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Bergman. A scholar is included among the top collaborators of Kimberly Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Bergman. Kimberly Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Datta, Indrani, Kimberly Bergman, Thaís S. Sabedot, et al.. (2025). Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment. PLoS ONE. 20(2). e0315171–e0315171.
2.
Wu, Kunyi, Suyoung Choi, Kimberly Bergman, & Shirley K. Seo. (2021). Antimicrobial Dose Selection under the Animal Rule. Clinical Pharmacology & Therapeutics. 109(4). 971–976. 3 indexed citations
3.
Wu, Kunyi & Kimberly Bergman. (2020). Dose Selection in a Pandemic: A Framework Informed by the FDA Animal Rule. Clinical and Translational Science. 14(1). 5–7. 1 indexed citations
4.
Fan, Jianghong, Xinyuan Zhang, Jiang Liu, et al.. (2020). Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019. Clinical Infectious Diseases. 71(12). 3232–3236. 60 indexed citations
5.
Bergman, Kimberly, et al.. (2017). Modeling and simulation in dose determination for biodefense products approved under the FDA animal rule. Journal of Pharmacokinetics and Pharmacodynamics. 44(2). 153–160. 5 indexed citations
6.
Bergman, Kimberly, et al.. (2015). The Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens. Clinical Infectious Diseases. 61(suppl 1). S32–S33. 18 indexed citations
7.
Bergman, Kimberly, Susan M. Irtenkauf, Laura Hasselbach, et al.. (2015). Abstract 1755: TORK/DNA-PK inhibitor CC-115 is effective as a single agent in a subset of glioblastoma patient-derived cancer stem cells and xenografts and potentiates temozolomide therapy. Cancer Research. 75(15_Supplement). 1755–1755. 2 indexed citations
8.
Sheffield, Jeanne S., David Siegel, Mark Mirochnick, et al.. (2014). Designing Drug Trials: Considerations for Pregnant Women. Clinical Infectious Diseases. 59(suppl_7). S437–S444. 78 indexed citations
9.
Lederman, Edith, Whitni Davidson, Scott K. Smith, et al.. (2012). Progressive Vaccinia: Case Description and Laboratory-Guided Therapy With Vaccinia Immune Globulin, ST-246, and CMX001. The Journal of Infectious Diseases. 206(9). 1372–1385. 90 indexed citations
10.
Bergman, Kimberly. (2009). The Animal Rule and Emerging Infections: The Role of Clinical Pharmacology in Determining an Effective Dose. Clinical Pharmacology & Therapeutics. 86(3). 328–331. 7 indexed citations
11.
Kaufman, Stuart S., Elizabeth Lyden, Keith M. Olsen, et al.. (2002). Omeprozole Therapy in Pediatric Patients After Liver and Intestinal Transplantation. Journal of Pediatric Gastroenterology and Nutrition. 34(2). 194–198. 15 indexed citations
12.
Monaghan, Michael S., Michael Marx, Keith M. Olsen, Paul D. Turner, & Kimberly Bergman. (2001). Correlation and Prediction of Phenytoin Protein Binding Using Standard Laboratory Parameters in Patients After Renal Transplantation. Therapeutic Drug Monitoring. 23(3). 263–267. 9 indexed citations
13.
Olsen, Keith M., Kimberly Bergman, Stuart S. Kaufman, Jill A. Rebuck, & Dean Collier. (2001). Omeprazole pharmacodynamics and gastric acid suppression in critically ill pediatric transplant patients. Pediatric Critical Care Medicine. 2(3). 232–237. 16 indexed citations
14.
Olsen, Keith M., et al.. (2000). Stability of Suspension Formulations of Lansoprazole and Omeprazole Stored in Amber-Colored Plastic Oral Syringes. Annals of Pharmacotherapy. 34(5). 600–605. 36 indexed citations
15.
Olsen, Keith M., et al.. (2000). Stability of Suspension Formulations of Lansoprazole and Omeprazole Stored in Amber-Colored Plastic Oral Syringes. Annals of Pharmacotherapy. 34. 600–605. 2 indexed citations
16.
17.
Bergman, Kimberly, et al.. (1999). PHARMACODYNAMICS OF OMEPRAZOLE SUSPENSION IN CRITICALLY ILL PEDIATRIC LIVER/INTESTINAL TRANSPLANT PATIENTS. Critical Care Medicine. 27(Supplement). 171A–171A. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maame Efua Sampah Breakdown of academic impact, for papers by Alberto Martín-Hidalgo Breakdown of academic impact, for papers by Eduardo Martínez Breakdown of academic impact, for papers by Patricia K. Mydlow Breakdown of academic impact, for papers by Nancy Perrottet Breakdown of academic impact, for papers by Sahera Dirajlal‐Fargo Breakdown of academic impact, for papers by Augustine Ebonyi Breakdown of academic impact, for papers by Joseph Stavola Breakdown of academic impact, for papers by Minh Lê Breakdown of academic impact, for papers by Marita Stevens
Rankless by CCL
2026